CU-CPT17e

CAS No. 2109805-75-4

CU-CPT17e( —— )

Catalog No. M23960 CAS No. 2109805-75-4

CU-CPT17e is a potent agonist of TLR(TLR3, TLR8, and TLR9).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 419 In Stock
10MG 617 In Stock
25MG 938 In Stock
50MG 1293 In Stock
100MG 1739 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CU-CPT17e
  • Note
    Research use only, not for human use.
  • Brief Description
    CU-CPT17e is a potent agonist of TLR(TLR3, TLR8, and TLR9).
  • Description
    CU-CPT17e is a potent agonist of TLR(TLR3, TLR8, and TLR9).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    TLR
  • Recptor
    TLR3|TLR8|TLR9
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2109805-75-4
  • Formula Weight
    504.49
  • Molecular Formula
    C27H24N2O8
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM (Need ultrasonic and warming)
  • SMILES
    O=[N+]([O-])C(C=C1)=CC=C1COC2=CC(C=CC3(CCOCC3)O4)=C4C=C2OCC5=CC=C([N+]([O-])=O)C=C5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhang L, et al. Discovery of Small Molecules as Multi-Toll-like Receptor Agonists with Proinflammatory and Anticancer Activities. J Med Chem. 2017 Jun 22;60(12):5029-5044.
molnova catalog
related products
  • Okanin

    Okanin shows significant activities on both linoleic acid peroxidation inhibition and DPPH radical scavenging effect.

  • CU-CPT9b

    CU-CPT9b is an antagonist of toll-like receptor 8 (TLR8;?Kd = 21 nM).?It inhibits activation of NF-?B induced by the TLR8 agonist R-848 in TLR8-overexpressing HEK-Blue cells with an IC50 value of 0.7 nM.

  • SM360320

    SM360320 is an effective and selective agonist of TLR7. SM360320 inhibits HCV replication in hepatocytes via a type I IFN-independent mechanism in addition to its IFN-mediated activity.